Achieve Life Sciences
ACHV
ACHV
29 hedge funds and large institutions have $17.3M invested in Achieve Life Sciences in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5.22% more ownership
Funds ownership: 16.38% → 21.6% (+5.2%)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.41M | |
| 2 | +$1.18M | |
| 3 | +$1.12M | |
| 4 |
ACM
Altium Capital Management
New York
|
+$1.1M |
| 5 |
CC
Clearline Capital
New York
|
+$1.09M |
Top Sellers
| 1 | -$3.29M | |
| 2 | -$423K | |
| 3 | -$387K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$144K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10.4K |